When every second counts…
Instant Access to Overdose Medication
NOS is a special patent-pending plastic cap containing Naloxone in a simple spray atomizer, which snaps directly on top of the opioid prescription bottle.
People die each day from opioid-related drug overdose³
People misuse prescription opioids annually¹
People died from opioid overdoses in 2017²
People had an opioid use disorder in 2016¹
People misused prescription opioids for the first time in 2016¹
Deaths attributed to overdose on commonly prescribed opioids in 2017²
Deaths attributed to overdose on synthetic opioids other than methadone in 2017²
Adolescents started to misuse prescription pain medications in 2017
A person is more likely to die from an accidental opioid overdose than from a motor vehicle crash.⁴
When Every Second Counts
CounterAct has developed a patent-pending, Emergency Nasal Overdose Spray Cap that snaps on top of any bottle of prescription opioid medicine.
The company is awaiting FDA approval prior to marketing, and so all descriptions are provided for reference only. Below is an explanation for its intended use:
In a typical opioid overdose emergency, it takes precious minutes for 911 emergency medical personnel to arrive on scene, administer an opioid counter agent such as Naloxone, then transport the victim to a hospital.
Some non-medical emergency responders may not have an overdose counter agent available, and may require substantially more time to obtain critical intervention.
The CounterAct Cap has an emergency opioid counter-agent nasal spray dispenser under its safety cap. No medical training is necessary to use the device.
In just SECONDS – not minutes, anyone who discovers a semi-conscious, or unconscious overdose victim can use CounterAct to instantly administer an emergency dosage of counter agent drug.
Call 911, then administer the CounterAct spray. Inform the Emergency personnel immediately upon arrival and inform them how long since the victim received the counter agent.
Opioid antidote can be given with prescription By BRADLEY J. FIKES AUG. 7, 2019 6 AM CounterAct, a startup founded by residents of Vista and Salt Lake City, has developed what it says is the most efficient way to get an antidote to opioid overdose patients. Called the...
In this article, Todd Pizitz, PhD, and Donald Mealing, both Co-Founders of CounterAct, discuss the ongoing opioid crisis in the US and the current use of the opioid reversal medication naxalone, and introduce the CounterAct device for naxalone home use. In the US in...
Legally mandating naloxone coprescriptions for patients at high risk for opioid overdose was tied to a 7.75-fold increase in dispensed naloxone prescriptions, according to study results published in JAMA Network Open. The findings suggest that legal mandates for...
Statement from FDA Commissioner on agency’s efforts to increase the availability of naloxone as one means for reducing opioid overdose deaths
With the number of overdose deaths from prescription and illicit opioids doubling from 21,089 in 2010 to 42,249 in 2016, it’s critical that we continue to tackle this human tragedy from all fronts – including, and importantly, looking at new ways to increase the...
Sources: 1 2016 National Survey on Drug Use and Health, 2 Mortality in the United States, 2016 NCHS Data Brief No. 293, December 2017, 3 CEA Report: The underestimated cost of the opioid crisis, 2017, 3 National Center for Health Statistics 2017 Final Data for Drug Overdose Deaths, 4 National Safety Council, January 2019